PALMETTO LOW COUNTRY BHD — History
CCN 424006 | 3-year financial timeline | COVID resilience: 29/100
🛡️ Public data only — no PHI permitted on this instance.
$14M
Latest Revenue (FY2022)
-2.8%
Revenue CAGR (3yr)
-7.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | $13M | $14M | +8.1% | -2.8% |
| Operating Expenses | $14M | $13M | $15M | +10.7% | +4.0% |
| Operating Margin | 6.6% | -4.4% | -7.0% | -58.3% | +0.0% |
| Net Income | $1M | $-1M | $-1M | -71.1% | +0.0% |
| Licensed Beds | 108 | 108 | 108 | +0.0% | +0.0% |
| Total Patient Days | 24,057 | 20,158 | 20,534 | +1.9% | -7.6% |
| Medicare Day % | 12% | 6% | 6% | +3.0% | -30.9% |
| Medicaid Day % | 1% | 2% | 1% | -39.2% | -17.1% |
COVID Impact & Recovery
Resilience Score: 29/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -5.6% ($15M → $14M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-2.8%
This Hospital
+7.6%
State Avg
Latest Margin
-7.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $13M | -13.7% |
| FY2024 (proj) | $13M | -20.5% |
| FY2025 (proj) | $13M | -27.3% |